Sell 10/18/2024Downgrade
ABIVAX Société Anonyme (AAVXF) was downgraded to E+ from D- on 10/18/2024 due to a decline in the total return index, valuation index and solvency index.

Sell 5/15/2024Upgraded
ABIVAX Société Anonyme (AAVXF) was upgraded to D- from E+ on 5/15/2024 due to an increase in the total return index, valuation index and growth index. Operating cash flow increased 1.09% from -$37.84M to -$37.43M, EBIT increased 1.09% from -$49.08M to -$48.54M, and earnings per share increased from -$1.0378 to -$1.0265.

Sell 12/5/2023Downgrade
ABIVAX Société Anonyme (AAVXF) was downgraded to E+ from D- on 12/5/2023 due to a decline in the total return index, volatility index and growth index.

Sell 10/6/2023Upgraded
ABIVAX Société Anonyme (AAVXF) was upgraded to D- from E+ on 10/6/2023 due to a substantial increase in the solvency index, growth index and valuation index. Total revenue increased 1.5% from $1.21M to $1.22M.

Sell 10/3/2023None
ABIVAX Société Anonyme (AAVXF) was downgraded to E+ from U on 10/03/2023.